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Specific Disruption of a Schwann Cell
Dystrophin-Related Protein Complex
in a Demyelinating Neuropathy
Matsumura et al., 1993). Recently, a third member of the
dystrophin family, dystrophin-related protein 2 (DRP2),
has been identified, the transcript of which is reported
to be enriched in the CNS (Dixon et al., 1997; Roberts
et al., 1996; Roberts and Sheng, 2000). Nevertheless,
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thus far, DRP2 has not been shown to be a componentUnited Kingdom
of a DGC.
In recent years, the signaling role of DGCs has been
increasingly recognized with the identification of the
Summary syntrophins, PDZ domain-containing proteins that inter-
act with dystrophin (Ahn et al., 1996; Ahn and Kunkel,
Dystroglycan-dystrophin complexes are believed to 1993; Froehner et al., 1997). PDZ domains are protein-
have structural and signaling functions by linking extra- interaction motifs implicated in the assembly of macro-
cellular matrix proteins to the cytoskeleton and cortical molecular-signaling complexes (Kornau et al., 1997;
signaling molecules. Here we characterize a dystro- Tsunoda et al., 1997). We have characterized the PDZ
glycan-dystrophin-related protein 2 (DRP2) complex domain-containing protein L-periaxin as a candidate
member of a signaling complex at the Schwann cellat the surface of myelin-forming Schwann cells. The
plasma membrane (Gillespie et al., 1994; Scherer et al.,complex is clustered by the interaction of DRP2 with
1995; Dytrych et al., 1998). Mice that lack a functionalL-periaxin, a homodimeric PDZ domain-containing
Prx gene ensheath and myelinate peripheral nerve axonsprotein. In the absence of L-periaxin, DRP2 is mislocal-
in an apparently normal manner, but the sheath destabi-ized and depleted, although other dystrophin family
lizes and the mice develop a severe demyelinating neu-proteins are unaffected. Disruption of the DRP2-dys-
ropathy (Gillespie et al., 2000). These data suggest thattroglycan complex is followed by hypermyelination
the periaxins play an essential role in stabilizing theand destabilization of the Schwann cell-axon unit in
Schwann cell-axon unit in the myelinated fibers of thePrx/ mice. Hence, the DRP2-dystroglycan complex
vertebrate PNS. This view is supported by the recentlikely has a distinct function in the terminal stages
discovery of autosomal recessive forms of Charcot-
of PNS myelinogenesis, possibly in the regulation of Marie-Tooth (CMT) disease caused by mutations in the
myelin thickness. human PRX gene (Boerkoel et al., 2001; Guilbot et al.,
2001).
Introduction In order to elucidate the pathophysiology of both the
human disease and the mouse model, we undertook
The dystrophin-glycoprotein complex (DGC) has been to identify the putative-signaling complex in which the
well characterized in skeletal muscle where it links extra- periaxins participate. Here we show that L-periaxin is
cellular proteins, such as the laminins of the basal lam- linked to a previously unknown dystroglycan complex
ina, to dystrophin and the cortical actin cytoskeleton by by the dystrophin-related protein DRP2. L-periaxin di-
virtue of their interactions with - and -dystroglycan, merizes at its PDZ domain, which probably contributes
respectively (Ahn and Kunkel, 1993; Gee et al., 1993; to the distinctive clustering of the complex in the
Ibraghimov-Beskrovnaya et al., 1992; Yamada et al., Schwann cell plasma membrane. Without L-periaxin,
1996a, 1996b). Mutations in components of the DGC the complex is mislocalized and DRP2 is unstable, in
disrupt the complex and cause several types of muscu- striking parallel to the aberrant DGCs in some of the
lar dystrophy (reviewed in Straub and Campbell, 1997), muscular dystrophies. It seems likely that the character-
possibly due to a lack of mechanical buffering against ization of other components of this dystroglycan com-
the shearing forces of contraction (Pasternak et al., plex will identify candidate genes for other autosomal
1995; Petrof et al., 1993; Stevenson et al., 1997). recessive forms of CMT.
Dystrophin-dystroglycan complexes are also widely
distributed in the vertebrate nervous system. In the pe-
ripheral nervous system (PNS), Schwann cells express Results
dystroglycan and a truncated form of dystrophin, Dp116
(Matsumura et al., 1993, 1997a, 1997c; Yamada et al., Interaction and Colocalization of L-Periaxin
1994). DGCs in the PNS have been implicated in mediat- with DRP2
ing the responsiveness of Schwann cells to extracellular To identify proteins that interact with L-periaxin, we
signals from laminin-2, because contact with the basal screened a sciatic nerve cDNA library by the yeast two-
lamina modulates the expression of genes required for hybrid system using as bait the N terminus of the protein
myelination (Bunge et al., 1986, 1990; Carey et al., 1986; (aa 2–459), which includes the PDZ domain and basic
Eldridge et al., 1989). A second gene of the dystrophin domain (Figure 1C) (Dytrych et al., 1998; Sherman and
family encoding utrophin (dystrophin-related protein 1) Brophy, 2000). Seven overlapping DRP2 clones were
is also expressed in Schwann cells (Love et al., 1989; isolated from a total of 1.6  106 colonies, two of which
were only one and ten amino acids longer, respectively,
than clone 39–374 and are not displayed (Figure 1A).1 Correspondence: peter.brophy@ed.ac.uk
No other dystrophin or dystrophin-related cDNAs were2 Present address: Department of Biology, University of Rome III,
Italy. found. The full-length cDNA encoding DRP2 was ob-
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Figure 1. Interaction of L-Periaxin and DRP2
(A) Structure of full-length DRP2 and the different DRP2 clones isolated from the yeast two-hybrid screen using L-periaxin (aa 2–459) fused
to the GAL4 DNA binding domain as bait. Numbers in brackets refer to amino acids.
(B) Identification of the DRP2 binding domain for L-periaxin. The strength of interaction between L-periaxin (aa 2–459) and a series of DRP2
constructs in a yeast two-hybrid -galactosidase assay was assessed semi-quantitatively by the time taken for colonies to turn blue (,
30 min; , 30–60 min; , 60–180 min). Interaction of DRP2 with utrophin and Dp116 is compared. Numbers in brackets refer to amino
acids.
(C) Identification of the L-periaxin binding domain for DRP2. The strength of interaction between DRP2 (aa 39–384) and a series of L-periaxin
deletion constructs in a yeast two-hybrid assay was assessed semi-quantitatively by the time taken for colonies to turn blue. A schematic
diagram of the full-length L-periaxin is shown for comparison. Numbers in brackets refer to amino acids.
(D) Interaction of the binding domains of L-periaxin and DRP2 in vitro. GST or a GST-fusion protein of DRP2 (aa 110–384) were incubated
with 35S-labeled L-periaxin (aa 2–379) generated by transcription and translation in vitro. Radioactively labeled L-periaxin in the recovered
GST and GST-fusion protein fraction was detected after SDS-PAGE and autoradiography. The input lane only contained radioactive L-periaxin.
(E) Biochemical interaction between the L-periaxin binding domain of DRP2 and full-length L-periaxin. GST or a GST-fusion protein of DRP2
(aa 110–384) were incubated with sciatic nerve lysate and any bound L-periaxin was detected by Western blotting using an L-periaxin antibody
after SDS-PAGE. The input lane confirms the presence of L-periaxin in the lysate.
tained by screening a rat sciatic nerve cDNA library and tify the specific regions responsible for protein-protein
interaction by monitoring -gal activity. It was strikingby 5 RACE (see Experimental Procedures and Figure
1A) and the deduced amino acid sequence was identical that all of the DRP2 clones from the two-hybrid screen
included spectrin-like repeats and at least part of theto that recently reported with the exception of the follow-
ing four changes: K525Q, R642K, H928L, and S929C adjacent WW domain, both of which are conserved in
dystrophin and the dystrophin-related proteins (Figure(Roberts and Sheng, 2000). To confirm that both L-peri-
axin and DRP2 are required to activate GAL4 transcrip- 1A; for review see Winder, 1997). Consistent with these
observations, the minimal region required for interactiontion, we established that transformation of yeast cells
with L-periaxin and DRP2 cDNAs was necessary both with L-periaxin comprised the two spectrin-like repeats
of the DRP polypeptide (Figure 1B). The WW domainfor -galactosidase (-gal) activity and for growth of
colonies on plates lacking histidine. was not essential, although there was some attenuation
in the strength of interaction with L-periaxin when thisTruncation of DRP2 and L-periaxin allowed us to iden-
A Periaxin-DRP2 Complex in the PNS
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region was truncated (Figure 1B). In order to determine DRP2 protein was very low in these tissues by compari-
if the binding of L-periaxin were specific for DRP2, we son with myelinated peripheral nerve (Figure 3A). West-
compared this interaction in a yeast two-hybrid assay ern blotting with an antibody raised against a different
with the ability of L-periaxin to associate with the analo- DRP2 peptide gave identical results (data not shown).
gous domains of the two other members of the dys- Overexposure of the Western blot did reveal trace levels
trophin family found in Schwann cells, namely Dp116 of DRP2 in other tissues; similarly, using DRP-specific
and utrophin. The equivalent regions of Dp116 and riboprobes, we also detected weak signals by in situ
utrophin displayed no propensity to interact with L-peri- hybridization in brain.
axin even in the presence of their WW domains The best characterized dystrophin and dystrophin-
(Figure 1B). related protein complexes with dystroglycan are in skel-
The DRP2 binding site in L-periaxin was identified as etal muscle. Hence, it was of interest to compare the
a basic domain of three basic subdomains, BD1 (aa expression pattern of DRP2 with other members of such
116–145), BD2 (aa 146–176), and BD3 (aa 176–196), complexes in both peripheral nerve and skeletal muscle.
which has been characterized previously as a nuclear The restriction of DRP2 expression to Schwann cells
localization signal (NLS) (Figure 1C) (Gillespie et al., was in striking contrast to the other two members of
1994; Sherman and Brophy, 2000). A construct trun- the dystrophin family, dystrophin (Dp116 in the PNS)
cated by the removal of amino acids 130–140 at the N and utrophin, and to -dystroglycan and -dystroglycan
terminus of the basic domain bound considerably less (Figure 3B). Note that utrophin is also expressed in the
well to DRP2 (Figure 1C). These ten amino acids include perineurium (arrow).
the four contiguous lysines of BD1. BD1 has also been Thus, the results of yeast two-hybrid experiments,
shown to be essential for NLS function (Sherman and biochemical studies, and immunolocalization analysis
Brophy, 2000). Indeed, BD1 has substantial NLS activity converge to the conclusion that L-periaxin and DRP2
on its own (Sherman and Brophy, 2000), in contrast to are present in a complex that is primarily expressed in
its complete inability to bind DRP2 (Figure 1C). These the plasma membrane of Schwann cells.
results point to an essential role for most of the basic
domain in DRP2 interaction. Since the PDZ domain of
L-Periaxin Specifically Interacts with DRP2 andL-periaxin was not required for association with DRP2,
Dystroglycan to Form a Transmembrane Complexit was consistent that S-periaxin, a truncated periaxin
Like dystrophin and utrophin, DRP2 has a potential bind-isoform of 147 amino acids having the PDZ domain and
ing site for -dystroglycan. However, thus far, it has nota unique 20 amino acid C terminus, but lacking the basic
been demonstrated that DRP2 interacts with -dystro-domain, did not interact with DRP2 (Figure 1C) (Dytrych
glycan. Yeast two-hybrid experiments confirmed thatet al., 1998). Biochemical support for the interaction
DRP2 could bind directly to the cytoplasmic tail domainbetween L-periaxin and DRP2 was obtained by showing
of -dystroglycan (Figure 4A). Further, it has been pro-that a GST-DRP2 fusion protein (aa 110–384 of DRP2)
posed that not only the WW and EF hand domains butcoprecipitated with either a fragment of the L-periaxin
also the ZZ domain at the C terminus of both dystrophinprotein generated by transcription and translation in
and utrophin are required for optimal interaction withvitro (aa 2–379) (Figure 1D) or full-length L-periaxin from
-dystroglycan (Jung et al., 1995; Suzuki et al., 1994;a sciatic nerve lysate (Figure 1E).
Tommasi di Vignano et al., 2000). We found that thisIn order to confirm that the interaction between L-peri-
was also the case for DRP2 (Figure 4A). Hence, it ap-axin and DRP2 is physiologically relevant, we examined
peared that DRP2 localizes to the Schwann cell plasmathe subcellular and tissue distribution of DRP2. As has
membrane by virtue of its binding to -dystroglycan.been previously documented, L-periaxin was abun-
Because L-periaxin interacts with DRP2, we then at-dantly expressed in the Schwann cell plasma membrane
tempted to isolate the L-periaxin complex from periph-(Figure 2A) (Dytrych et al., 1998; Gillespie et al., 1994;
eral nerve lysates by immunoaffinity chromatographyScherer et al., 1995). DRP2 was found in the same loca-
using an affinity-purified antibody to L-periaxin (Figuretion and appeared to have a focal distribution in cross
4B). As expected, DRP2 copurified with L-periaxin, but,section (Figure 2A). The clusters of DRP2 were particu-
importantly, the complex also contained - and -dys-larly striking at the surface of teased myelinated fibers
troglycan which indicated that L-periaxin and DRP2(Figure 2B). Strong colocalization of L-periaxin with
were part of a DGC (Figure 4B). Since the utrophin andDRP2 was evident although it did appear that L-periaxin
dystrophin complexes have recently been shown to in-was also present outside of the clusters (Figures 2A and
teract in Schwann cells (Imamura et al., 2000), it was of2B). Like L-periaxin, DRP2 was not detectable in non
interest to determine if utrophin and Dp116 were alsomyelin-forming Schwann cells (data not shown). Immu-
associated with the DRP2 complex. Both were present,noelectron microscopy of a section of trigeminal nerve
which probably accounts for the presence of actin in theconfirmed that DRP2 and L-periaxin were both localized
complex because utrophin has an actin binding domainto the plasma membrane at the abaxonal surface of the
(Figure 4B). The low signal for -dystroglycan in theSchwann cell-axon unit (Figure 2C), and light micros-
Western blots is consistent with the proposal that thecopy of a cross section of trochlear nerve revealed that
interaction of DRP2 with -dystroglycan is relativelyseveral of these clusters could be detected at the sur-
weak, as has been found for the association of -dys-face of each Schwann cell in the same plane of the
troglycan with both utrophin and Dp116 in the Schwannsection (Figure 2D). Confocal analysis of a teased sciatic
cell plasma membrane (Imamura et al., 2000; Saito et al.,nerve fiber at three longitudinal optical sections, top,
1999). In addition to dystroglycan, myelinating Schwannmiddle and bottom, demonstrated the surface nature of
cells express a second laminin receptor, 64-integrinthese spheroidal DRP2 clusters.
(Einheber et al., 1993). However this was not present inDRP2 has been detected in a variety of tissues by RT-
the L-periaxin-DRP2 complex as shown by the absencePCR, including brain, colon, testis, ovary, and kidney
(Dixon et al., 1997). We found that expression of the of the 4 polypeptide (Figure 4B).
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Figure 2. Localization of DRP2 and L-Periaxin
(A) Confocal immunofluorescence analysis of transverse sections (P21) of mouse sciatic nerve double-labeled with a rabbit antibody against
DRP2 and a mouse antibody against L-periaxin. DRP2 and L-periaxin colocalize. Scale bar, 10 m.
(B) Confocal immunofluorescence analysis of a teased fiber (P26) of mouse sciatic nerve double-labeled as in (A). DRP2 and L-periaxin
colocalize in clusters at the upper surface of a teased fiber in confocal optical sections. Scale bar, 10 m.
(C) DRP2 is localized with L-periaxin at the Schwann cell plasma membrane. In transverse section, DRP2 (10 nm gold particles, arrows) and
L-periaxin (5 nm gold particles, arrowheads) are primarily localized to the abaxonal Schwann cell plasma membrane in P28 rat trigeminal
nerve by immunoelectron microscopy. Myelin (m) is unlabeled. Scale bar, 100 nm.
(D) DRP2 clusters at the abaxonal Schwann cell surface. Transmitted light images of trochlear nerve sections showing the myelin sheath
(arrow) were overlayed with the immunofluorescence labeling pattern of DRP2 (arrowheads) Scale bar, 5 m.
(E) Spheroidal clusters of DRP2 at the surface of the Schwann cell. Three longitudinal confocal-optical sections at the top, middle, and bottom
of a teased sciatic nerve fiber immunostained for DRP2 demonstrate that the surface of the Schwann cell is extensively decorated with
spheroidal clusters of DRP2. Scale bar, 10 m.
These experiments established that L-periaxin and obvious disruption to the localization of -dystroglycan
(Figure 5A). The specificity of the dramatic loss of DRP2DRP2 are constituents of a transmembrane complex of
the DGC type. in periaxin-deficient peripheral nerves was confirmed
by Western blot which also showed that -dystroglycan,
-dystroglycan, Dp116, and utrophin were unaffectedL-Periaxin Is Required to Cluster and Stabilize
(Figure 5B).the DRP2-Dystroglycan Complex
Clustering of DRP2 appeared to require L-periaxin,We have previously shown that the peripheral nerves of
which suggested that the latter might provide the scaf-periaxin-deficient mice display a late-onset, demyelinat-
fold on which the DRP2 DGC assembles. An analogousing neuropathy (Gillespie et al., 2000). However, it was
function has been proposed for a variety of other PDZ-unclear why loss of the periaxins should destabilize
domain containing proteins in multiprotein, cortical sig-axon-Schwann cell interaction after myelination was es-
naling complexes. In order to identify other proteins withsentially complete. Hence, we wished to determine if
which the PDZ domain in the N terminus of L-periaxinthe loss of L-periaxin might influence the organization of
might interact, we repeated the yeast two-hybrid screenthe DRP2-dystroglycan complex. Immunofluorescence
of a rat peripheral nerve cDNA library using the N termi-analysis of Prx/ mice revealed an apparent loss of
nus of the protein (aa 2–164) as bait. This truncatedDRP2 in the Schwann cell plasma membrane by com-
version of L-periaxin contained the PDZ domain andparison with wild-type nerves, and the little DRP2 that
part of the basic domain, although it would have beenremained was no longer clustered in patches but dif-
fusely distributed (Figure 5A). In contrast, there was no insufficiently large to interact with DRP2. Ten overlap-
A Periaxin-DRP2 Complex in the PNS
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(	2–103) (Figure 6A) suggesting that the canonical pep-
tide binding groove of periaxin’s PDZ domain partici-
pated in homodimerization.
Biochemical evidence for the ability of L-periaxin to
dimerize was obtained by means of a “pull-down” assay.
A GST-fusion protein that included the same region of
L-periaxin as was used in the two-hybrid screen was
able to bind intact L-periaxin in a sciatic nerve lysate
(Figure 6B). In support of the two-hybrid data, truncation
of the N terminus of L-periaxin to the core PDZ domain
attenuated homodimerization with the full-length protein
to a point where it was no longer detectable by affinity
chromatography (Figure 6B). To confirm that full-length
L-periaxin could homodimerize in a cellular environ-
ment, we showed that myc-tagged periaxin could be
coimmuneprecipitated with FLAG-tagged periaxin when
both were expressed in COS cells (Figure 6C). These
results point to the ability of L-periaxin to cross-link
DRP2-dystroglycan complexes in the submembranous
cortex of the Schwann cell by virtue of its ability to
homodimerize and account for the loss of DRP2 cluster-
ing in the peripheral nerves of Prx/ mice. A model for
the DRP2 complex is presented in Figure 7.
Discussion
We have identified a peripheral demyelinating neuropa-
thy in which a specific dystrophin-related protein com-
plex is disrupted by the loss of L-periaxin. A central
feature of this macromolecular structure is the impor-
tance of L-periaxin to the stability of the complex
through its interaction with the dystrophin-related pro-
tein, DRP2. This interaction is specific in that L-periaxin
does not associate directly with either of the other two
members of the dystrophin family found in Schwann
cells, namely dystrophin (Dp116) and utrophin, which
suggests that these proteins are members of distinct
dystroglycan complexes. This conclusion is supported
by the fact that neither utrophin nor DRP2 can function-
ally substitute for Dp116 in the peripheral nerves of pa-
Figure 3. DRP2 Is Primarily a PNS Protein tients with a severe form of muscular dystrophy (Comi
(A) Homogenates (15 g protein) of mouse tissues were separated et al., 1995).
by SDS-PAGE and DRP2 was detected by Western blotting using Although Prx null mice myelinate in an ostensibly nor-
a DRP2 antibody. The blots were stripped and reprobed with an mal fashion, they develop a severe, late-onset demyelin-
antibody against actin as a loading control for PNS and CNS tissue. ating neuropathy in which the myelin sheath becomes
DRP2 protein was only detected in the PNS.
unstable (Gillespie et al., 2000). In the absence of L-peri-(B) Specificity of DRP2 expression in the PNS. Cross sections of
axin, the earliest evidence for morphological disruptionmouse quadriceps muscle and a myelinated nerve fiber at P21 were
of the axon-Schwann cell unit is the focal thickening ofdouble-labeled with a rabbit antibody against DRP2 and mouse
the sheath. The ensuing overproduction of myelin ismonoclonal antibodies against dystrophin, utrophin, -dystrogly-
can, or -dystroglycan. Only Schwann cells in the nerve contain followed by demyelination and remyelination. The re-
DRP2, whereas the other dystroglycan-complex proteins are ex- sults reported here implicate the L-periaxin-DRP2-dys-
pressed in both Schwann cells and skeletal muscle. Utrophin is also troglycan complex in the regulation of the terminal
found in the perineurium (arrow). Scale bar, 20 m. stages of myelination. This view is consistent with the
fact that the Prx gene is regulated by axonal contact,
and that the thickness of the sheath is believed to be
determined by the axon (Lemke and Chao, 1988; Schererping L-periaxin clones were recovered from a screen of
one million clones, which strongly suggested that L-peri- et al., 1995). It is also consistent with the fact that the
translocation of L-periaxin to a predominantly abaxonalaxin could homodimerize. Interestingly, truncation of the
N-terminal fragment of L-periaxin revealed that the mini- location at the Schwann cell plasma membrane is a
relatively late event during myelination (Dytrych et al.,mal PDZ domain (aa 2–103) formed homodimers less
effectively (Figure 6A). In order to determine if homodi- 1998; Gillespie et al., 1994; Scherer et al., 1995). There-
fore, association of L-periaxin with the cortical DRP2merization involved the peptide binding regions analo-
gous to those of other PDZ domains, we mutated the complex appears to be a feature of the maturation of the
sheath, in concordance with the late-onset phenotype ofadjacent G and F amino acids in the carboxylate binding
loop (Dytrych et al., 1998). Homodimerization was atten- the periaxin-deficient mouse.
The production and deposition of basement mem-uated even further in the mutated-core PDZ domain
Neuron
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Figure 4. The L-Periaxin-DRP2-Dystrogly-
can Complex
(A) DRP2 interacts with -dystroglycan. The
strength of the interaction of the cytoplasmic
carboxy-terminal domain of -dystroglycan
(-DG) with truncated versions of DRP2 was
assessed by a semi-quantitative yeast two-
hybrid assay.
(B) Immunoaffinity-purification of the L-peri-
axin-DRP2-dystroglycan complex. Detergent
extracts of mouse sciatic nerve in the non-
ionic detergent Igepal were incubated with
beads to which affinity-purified sheep anti-L-
periaxin antibodies had been covalently cou-
pled. After extensive washing, bound pro-
teins were eluted and analyzed by Western
blotting after SDS-PAGE. The SDS control
lane contains proteins that bound to the
beads after first solubilizing the nerves in SDS
followed by dilution of the SDS with Triton
X-100. The presence of the proteins in the
Igepal lysate is shown in the input lane. Im-
munaffinity purification of L-periaxin from both
SDS- and Igepal-solubilized lysates is shown
in the Coomassie-blue-stained gel.
brane by the Schwann cell around the axon-Schwann autocrine nature of this relationship is illustrated by the
defects in myelination observed in laminin-2 deficiency,cell unit is also under axonal control (Bunge and Bunge,
1978; Doyu et al., 1993). The basal lamina has an essen- as occur in congenital muscular dystrophy (CMD) and
in the dy/dy mouse (Arahata et al., 1993; Matsumura ettial role in promoting the development of the myelinating
Schwann cell and in stabilizing Schwann cell-axon inter- al., 1997b; Sunada et al., 1994; Uziyel et al., 2000; Xu et
al., 1994). Derangements in the structure or signalingaction (Carey et al., 1986; Eldridge et al., 1989). The
Figure 5. DRP2 Is Specifically Mislocalized and Depleted in Periaxin Null Mice
(A) Immunofluorescence localization of DRP2 and -dystroglycan (-DG) in teased sciatic nerve fibers of wild-type mice (/) and periaxin
null homozygotes (/). Confocal optical sections through the center of the Prx/ fiber reveal the clustered localization of DRP2, whereas
-dystroglycan has a more uniform distribution at the Schwann cell plasma membrane which is not changed in the Prx/ nerve. In contrast,
DRP2 is no longer clustered in Prx/ sciatic nerves, it also appears to be reduced in quantity.
(B) DRP2 is specifically depleted in the absence of L-periaxin. SDS-solubilized sciatic nerves (10 g protein) from wild-type mice (/) and
periaxin null homozygotes (/) were analyzed by Western blot after SDS-PAGE. DRP2 is the only major constituent of the DGC to be
depleted.
A Periaxin-DRP2 Complex in the PNS
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Figure 7. Model of the L-Periaxin-DRP2 Complex at the Schwann
Cell Plasma Membrane
The ability of the PDZ domain of L-periaxin to homodimerize may
account for the clustering of DRP2. The mechanism of linkage of
the utrophin and Dp116 complexes to the L-periaxin-DRP2-dystro-
glycan complex is not yet clear. SG, sarcoglycans; , , - and
-dystroglycan.
between the PDZ domains of neuronal nitric oxide syn-
thase (nNOS) and syntrophin has been shown to be a
consequence of the interaction of the canonical peptide
Figure 6. L-Periaxin Homodimerizes
binding groove of syntrophin with a -hairpin “finger”
(A) Yeast two-hybrid analysis of the region required for L-periaxin within the nNOS PDZ domain in a head-to-tail conforma-
homodimerization. The ability of truncated forms of L-periaxin to
tion (Hillier et al., 1999). Because mutation of two of thehomodimerize with the N terminus of the protein was analyzed semi-
amino acids in the GLGF motif in the putative carboxyl-quantitatively by determining the time taken for the development
ate binding loop of the periaxin PDZ domain from GFof -galactosidase activity and the ability of cotransfected yeast
to AA attenuated homodimerization, it seems likely thatcolonies to grow in the absence of histidine. Amino acids are in
brackets. The construct 	2–103 was mutated by the substitution of self-association of periaxin proceeds by a parallel mech-
the adjacent G and F amino acids in the carboxylate binding loop anism.
by alanines. S-periaxin represents the full-length isoform of the alter- The mislocalization and concomitant loss of DRP2 in
native product of the Prx gene. periaxin-deficient mice suggests not only that the ability
(B) The N terminus of L-periaxin interacts with full-length L-periaxin of L-periaxin to dimerize helps to cluster the complex
in vitro. Sciatic nerve lysates in 0.5% CHAPS were incubated with
but that the protein also selectively stabilizes the DRP2GST or GST-L-periaxin fusion proteins (GST/2–103, or 2–164) bound
DGC. In similar fashion, a reduction in membrane-asso-to agarose. Bound proteins were eluted and analyzed by SDS-PAGE
ciated dystrophin in the Mdx mouse leads to the lossand Western blotting with a rabbit anti-L-periaxin antiserum. The
of other components of the DGC, and mice deficient ininput lane represents a sample of lysate.
(C) Full-length L-periaxin homodimerizes in transfected COS7 cells. the dystrophin Dp71 have significantly less dystroglycan
COS7 cells transiently expressing FLAG-tagged L-periaxin (FLAG-P) in the brain (Ervasti et al., 1990; Greenberg et al., 1996).
alone or with myc-tagged L-periaxin (myc-P) were lysed in 0.2% Hence, it appears that assembly of the DGC stabilizes
CHAPS and myc-P was immunoprecipitated using a myc antibody. its component proteins. PDZ domain proteins have been
Immunoprecipitates were analyzed by Western blotting with FLAG shown to perform similar functions in other types of
(FLAG) or myc antibodies (myc). The input lanes contain samples
signaling complex. In Drosophila, INAD, a homodimericof cell lysate.
protein of the rhabdomere with five PDZ domains, stabi-
lizes the TRP channel protein, and the product of the
Dlg gene selectively prevents the destruction of the Fasproperties of receptor complexes for basement mem-
brane proteins, such as laminin-2, are also likely to affect II and Shaker channel proteins (Chevesich et al., 1997;
Li and Montell, 2000; Zito et al., 1997).myelination, as has been found when Dp116 is absent
from the PNS (Comi et al., 1995). Schwann cells are polarized cells with a membrane
in contact with basal lamina that is analogous to thePDZ domains normally interact with a group of con-
served peptide sequences found at the C termini of basolateral surface of an epithelial cell. DGCs have been
proposed to play a critical role in the differentiation ofcertain transmembrane proteins (Kornau et al., 1997).
The carboxylate binding loop has been shown to be a epithelial cells by helping to define the basolateral mem-
brane and by acting as foci for the assembly of cytoskel-key structural element of the peptide binding groove in
the PDZ domain and the GLGF motif is a highly con- eton-associated complexes (Drubin and Nelson, 1996;
Durbeej et al., 1995; Kachinsky et al., 1999). In this con-served feature of this structure (Doyle et al., 1996). In
periaxin, the equivalent sequence is GVSGF (Dytrych et text, and in contrast to Dp116, utrophin or, indeed, dys-
troglycan, the localized, focal nature of DRP2 in theal., 1998). It is now clear that PDZ domains can interact
with internal peptide sequences and that they may also Schwann cell plasma membrane is of particular interest;
it suggests that the clustering of the DRP2 DGC mighthomodimerize and heterodimerize (Cuppen et al., 1998;
Garner et al., 2000; Xu et al., 1998). The dimer formed influence the way the complex responds to extracellular
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for the development of blue colonies: , 30 min; , 30–60signals from basement membrane proteins such as lami-
min; , 60–180 min. All constructs generated by PCR were con-nin. These DGC clusters may also reflect the necessity
firmed by DNA sequencing.of bringing other signaling molecules that associate with
L-periaxin into close proximity. The other components
Primary Antibodiesof these clustered complexes remain to be determined.
All peptides were coupled to Keyhole Limpet hemocyanin and affin-However, it appears that they do include both utrophin
ity purified as described (Dytrych et al., 1998). DRP2 antibodies
and dystrophin, proteins known to associate in periph- 2164 and 2155 were raised in New Zealand white rabbits against
eral nerve with a sarcoglycan complex comprising -, synthetic peptides CSDVTANTLLAS (aa 947–957) and CEKLR-

- and -sarcoglycan (Imamura et al., 2000). The fragile HAFPSVRSSD (aa 935–948), respectively. A C-terminal L-periaxin
nature of the interaction between -dystroglycan and antibody (Peri-C2) was raised in sheep (Diagnostics Scotland, Car-
luke, UK) and directed against the synthetic peptide SGSKDREEGG-both utrophin and Dp116 in the Schwann cell plasma
FRVRLPSVGFSETAC (Research Genetics) corresponding to aminomembrane has been attributed to the absence of -sar-
acids 1345–1368 of rat L-periaxin. The L-periaxin antibody, 170pep1,coglycan (Imamura et al., 2000; Saito et al., 1999). This
was previously characterized (Gillespie et al.,1994). A mouse anti-might also explain the relatively low amounts of -dys-
body raised against the same peptide 170pep1M was also usedtroglycan in the L-periaxin-DRP2 complex.
for immunofluorescence. Monoclonal antibodies to -dystroglycan
The importance of L-periaxin to the function of the (MANDAG 2), and utrophin, (MANCHO 3), were generous gifts from
human PNS has been established by the recent discov- Dr. G.E. Morris (Morris et al., 1998) and an anti-4-integrin (clone
ery of autosomal-recessive forms of hereditary demye- 346–11A) was from Dr. S.J. Kennel (Oak Ridge). Anti--dystroglycan
linating sensorimotor neuropathy of the CMT type antibody and a monoclonal antibody against the C terminus of dys-
trophin, DYS2, were from Upstate Biotechnology and Novacastro,caused by a variety of mutations in the human PRX
Newcastle, UK respectively.gene (Boerkoel et al., 2001; Guilbot et al., 2001). The
similarities of the human disease, both clinically and
Western Blottinghistopathologically, to the phenotype of the periaxin-
For tissue Western analysis, tissue homogenates were separateddeficient mouse are striking (Boerkoel et al., 2001; Gilles-
by electrophoresis on 10% SDS-PAGE gels and subsequently trans-pie et al., 2000; Guilbot et al., 2001). The current work
ferred electrophoretically to nitrocellulose (Schleicher & Schuell) as
shows that such animal models can provide a powerful previously described (Gillespie et al., 1994). Membranes were
means to elucidate the molecular pathophysiology of blocked with PBS, 0.1% Tween 20, and 5% nonfat milk. Primary
disease (Dyck et al., 1993; Muller et al., 1997; Warner et antibody dilutions for Western blots were DRP2 (2155) 1:2000, dys-
al., 1999). Perhaps, even more importantly, the charac- trophin (DYS2), 1:40, utrophin (MANCHO 3), 1:500, -dystroglycan
(MANDAG 2), 1:500, -dystroglycan 1:2000, actin (Sigma) 1:1000,terization of the rest of the periaxin complex is likely
4-integrin 1:2000.to identify new candidate genes for other autosomal
recessive forms of CMT.
GST Fusion Protein Production
Rat L-periaxin (aa 2–103, aa 2–164) and DRP2 (aa 110–384) wereExperimental Procedures
amplified by PCR and subcloned in frame into pGEXKG for GST
fusion protein production. Recombinant proteins were overex-Yeast Two-Hybrid Screening and Interactions
pressed by induction of transformed E. coli BL21 CodonPlus-Two-hybrid screening was performed in the yeast strain Y190 (Clon-
RIL(DE3) (Stratagene) at log phase with 1 mM isopropyl-1-thio-D-tech). The N terminus of rat L-periaxin (aa 2–459) was the bait, and
galactopyranoside (IPTG) for 3 hr. The bacterial pellet was lysed bywas obtained by PCR amplification and subcloned in frame into the
sonication and the supernatant from a 15,000 rpm centrifugationEcoRI and BamHI sites of pAS2-1 (Clontech) to generate a GAL4
(SS34 rotor, Sorvall) was purified on a Glutathione-Sepharose 4Bbinding domain fusion protein. A random-primed rat sciatic nerve
(Amersham Pharmacia Biotech) column. Recombinant proteinslibrary was generated in ACTII. The entire library was subjected to
were eluted from the column with excess reduced glutathioneCre-lox excision and purified plasmid cDNAs were obtained using
(10 mM).a Qiagen Maxiprep kit. After cotransformation of the bait with 1.6 
106 library cDNA clones (Gietz and Schiestl., 1995) in the yeast strain
Y190 (Clontech) harboring HIS3 and lacZ as reporter genes, positive In Vitro Transcription and Translation
and Pulldown Experimentsclones were selected on plates lacking leucine, tryptophan, and
histidine containing 30 mM 3-aminotriazole. Positive clones were A truncated L-periaxin (aa 2–379) was generated and labeled by in
vitro transcription followed by translation using 35S-methionine in atested for -galactosidase activity by filter-lift assay. Interacting
clones were rescued and interactions were confirmed by yeast mat- reticulocyte lysate kit (Promega). Purified GST fusion proteins (GST
and GST-DRP2, 6 g) were coupled to Glutathione-Sepharoseing according to the manufacturers instructions (Clontech), and se-
quenced. For yeast mating, the bait in yeast strain Y187 (Clontech) beads (25 l, Amersham Pharmacia Biotech) by incubation for 40
min in binding buffer (50 mM Tris HCl [pH 7.5], 100 mM NaCl, 1 mMwas mated with the prey in strain Y190. The full-length DRP2 cDNA
was obtained by screening a random-primed P10 rat sciatic nerve EDTA, 0.5% NP40, 1 mM DTT, 1 mM PMSF, 5 g/ml leupeptin, 2
g/ml pepstatin, 0.5 mM TLCK). The washed beads were incubatedlibrary generated in gt11 using a 217 bp PCR fragment correspond-
ing to amino acids 734–805 and by 5 RACE using the GeneRacer with the 35S-labeled translation product (1  106 cpm) in binding
buffer for 1.5 hr at 4C. The beads were washed extensively inKit (Invitrogen). Deletion constructs of L-periaxin, S-periaxin, DRP2
and the C terminus of -dystroglycan were generated by PCR and binding buffer before solubilization in SDS-PAGE sample buffer.
Proteins were resolved in a 12% SDS-PAGE gel, Coomasie stainedsubcloned into either pAS2-1 to produce GAL4 binding domain fu-
sions or pACT2 to produce GAL4 activation domain fusions. PCR to confirm equivalent fusion protein loading and processed for fluo-
rography using Amplify (Amersham Pharmacia Biotech). For sciaticmutagenesis was performed using a Quikchange site-directed mu-
tagenesis kit (Stratagene). The mutations were subsequently con- nerve pull-down assays, the perineurial sheaths of P16 or P21 rat
sciatic nerves were removed, following which they were homoge-firmed by sequencing. The PDZ domain mutation was generated by
replacing glycine and phenylalanine at aa 31 and 32 of L-periaxin nized on ice in 25 mM Tris HCl (pH 7.5), 150 mM NaCl, 0.5% CHAPS,
50 mM NaF, 1 mM EDTA, 1 mM EGTA, 10 g/ml leupeptin, 10with alanines. pACT-Dp116 (aa 86–379) and pACT-utrophin (aa
2552–2848) were obtained by reverse transcription (RT) PCR using g/ml antipain, 0.5 mM TLCK, 0.7 g/ml chymostatin, 10 g/ml
benzamidine, 1 mM PMSF. The homogenate was centrifuged for 20P10 and P12 mouse sciatic nerve RNA as template. The interactions
were performed by cotransformation in Y190 or by yeast mating min at 13,000 g and the lysates were precleared by incubation for
45 min at 4C with 25 l Glutathione-Sepharose beads. The clearedand assayed for reporter gene expression. -galactosidase activity
by filter lift assay was scored semiquantitatively by the time taken lysate was then incubated for 45 min at room temperature with GST
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fusion protein bound to beads. The beads were washed five times phate buffer containing 3% sucrose (pH 7.4) and processed for
immunoelectron microscopy as described (Gillespie et al., 1994).with lysis buffer, proteins were eluted with SDS-PAGE sample buffer,
resolved on 8% SDS polyacrylamide gels, transferred to nitrocellu-
lose, and analyzed by Western blotting using anti-170pep1 Acknowledgments
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